GSK-3 in neurodegenerative diseases

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Lei, Peng ^a,b   Ayton, Scott ^a,b   Bush, Ashley I ^a,b   Adlard, Paul A ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; BETA SECRETASE; DOPAMINE; GAMMA SECRETASE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; MAGNESIUM ION; MOOD STABILIZER; NEUROPROTECTIVE AGENT; TAU PROTEIN; TOXIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL CULTURE; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG EFFICACY; ENZYME DEFECT; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SUBSTRATE; HAPLOINSUFFICIENCY; HUMAN; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSGENIC ANIMAL; UNSPECIFIED SIDE EFFECT; WORKING MEMORY;

EID: 79959266561     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/189246     Document Type: Review

References (156)

1. Embi N., Rylatt D. B., Cohen P., Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase European Journal of Biochemistry 1980 107 2 519 527
2. Rylatt D. B., Aitken A., Bilham T., Condon G. D., Embi N., Cohen P., Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase European Journal of Biochemistry 1980 107 2 529 537
3. Kockeritz L., Doble B., Patel S., Woodgett J. R., Glycogen synthase kinase-3an overview of an over-achieving protein kinase Current Drug Targets 2006 7 11 1377 1388 (Pubitemid 44718298)
4. Frame S., Cohen P., GSK3 takes centre stage more than 20 years after its discovery Biochemical Journal 2001 359 1 1 16 (Pubitemid 32939202)
5. Woodgett J. R., Molecular cloning and expression of glycogen synthase kinase-3/factor A The EMBO Journal 1990 9 8 2431 2438
6. Yao H. B., Shaw P. C., Wong C. C., Wan D. C. C., Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain Journal of Chemical Neuroanatomy 2002 23 4 291 297
7. Lau K. F., Miller C. C. J., Anderton B. H., Shaw P. C., Expression analysis of glycogen synthase kinase-3 in human tissues Journal of Peptide Research 1999 54 1 85 91 (Pubitemid 29334091)
8. Aoki M., Iwamoto-Sugai M., Sugiura I., Sasaki C., Hasegawa T., Okumura C., Sugio S., Kohno T., Matsuzaki T., Expression, purification and crystallization of human tau-protein kinase I/glycogen synthase kinase-3 β Acta Crystallographica Section D 2000 56 11 1464 1465
9. Dajani R., Fraser E., Roe S. M., Young N., Good V., Dale T. C., Pearl L. H., Crystal structure of glycogen synthase kinase 3 : structural basis for phosphate-primed substrate specificity and autoinhibition Cell 2001 105 6 721 732 (Pubitemid 32635102)
10. Soutar M. P. M., Kim W.-Y., Williamson R., Peggie M., Hastie C. J., McLauchlan H., Snider W. D., Gordon-Weeks P. R., Sutherland C., Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain Journal of Neurochemistry 2010 115 4 974 983
11. Cole A., Frame S., Cohen P., Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event Biochemical Journal 2004 377 1 249 255 (Pubitemid 38114452)
12. Cross D. A. E., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 1995 378 6559 785 789 (Pubitemid 26004411)
13. Lesort M., Jope R. S., Johnson G. V. W., Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3 and Fyn tyrosine kinase Journal of Neurochemistry 1999 72 2 576 584 (Pubitemid 29055219)
14. Liu S. J., Zhang AI. H., Li H. L., Wang Q., Deng H. M., Netzer W. J., Xu H., Wang J. Z., Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory Journal of Neurochemistry 2003 87 6 1333 1344 (Pubitemid 38020568)
15. Meske V., Albert F., Ohm T. G., Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2a- and glycogen synthase kinase-3 -dependent phosphorylation of tau Journal of Biological Chemistry 2008 283 1 100 109
16. Isagawa T., Mukai H., Oishi K., Taniguchi T., Hasegawa H., Kawamata T., Tanaka C., Ono Y., Dual effects of PKN and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3 Biochemical and Biophysical Research Communications 2000 273 1 209 212 (Pubitemid 30426888)
17. Tsujio I., Tanaka T., Kudo T., Nishikawa T., Shinozaki K., Grundke-Iqbal I., Iqbal K., Takeda M., Inactivation of glycogen synthase kinase-3 by protein kinase C : implications for regulation of phosphorylation FEBS Letters 2000 469 1 111 117 (Pubitemid 30119880)
18. Thornton T. M., Pedraza-Alva G., Deng B., Wood C. D., Aronshtam A., Clements J. L., Sabio G., Davis R. J., Matthews D. E., Doble B., Rincon M., Phosphorylation by p38 MAPK as an alternative pathway for GSK-3 inactivation Science 2008 320 5876 667 670 (Pubitemid 351928349)
19. Hernndez F., Langa E., Cuadros R., Avila J., Villanueva N., Regulation of GSK3 isoforms by phosphatases PP1 and PP2A Molecular and Cellular Biochemistry 2010 344 1-2 211 215
20. Peineau S., Taghibiglou C., Bradley C., Wong T. P., Liu L., Lu J., Lo E., Wu D., Saule E., Bouschet T., Matthews P., Isaac J. T. R., Bortolotto Z., Wang YU. T., Collingridge G. L., LTP inhibits LTD in the hippocampus via regulation of GSK-3 Neuron 2007 53 5 703 717 (Pubitemid 46283369)
21. Kim Y., Lee Y. I., Seo M., Kim SO. Y., Lee JI. E., Youn H. D., Kim Y. S., Juhnn Y. S., Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells Journal of Neurochemistry 2009 111 2 344 354
22. Liu G. P., Zhang Y., Yao X. Q., Zhang C. E., Fang J., Wang Q., Wang J. Z., Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms Neurobiology of Aging 2008 29 9 1348 1358 (Pubitemid 351970605)
23. Blennow K., de Leon M. J., Zetterberg H., Alzheimer's disease The Lancet 2006 368 9533 387 403 (Pubitemid 44108123)
24. Masters C. L., Simms G., Weinman N. A., Amyloid plaque core protein in Alzheimer disease and Down syndrome Proceedings of the National Academy of Sciences of the United States of America 1985 82 12 4245 4249 (Pubitemid 15053619)
25. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., Selkoe D. J., Amyloid -peptide is produced by cultured cells during normal metabolism Nature 1992 359 6393 322 325
26. Tanzi R. E., The Alzheimer disease-associated amyloid beta protein precursor gene and familial Alzheimer disease Progress in Clinical and Biological Research 1990 360 187 199
27. Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., Teplow D. B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M. A., Biere A. L., Curran E., Burgess T., Louis J. C., Collins F., Treanor J., Rogers G., Citron M., α-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 1999 286 5440 735 741
28. Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T., Selkoe D. J., Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and -secretase activity Nature 1999 398 6727 513 517
29. Grundke-Iqbal I., Iqbal K., Tung Y. C., Abnormal phosphorylation of the microtubule-associated protein (tau) in Alzheimer cytoskeletal pathology Proceedings of the National Academy of Sciences of the United States of America 1986 83 13 44913 4917
30. Grundke-Iqbal I., Iqbal K., Quinlan M., Microtubule-associated protein tau. A component of Alzheimer paired helical filaments Journal of Biological Chemistry 1986 261 13 6084 6089 (Pubitemid 17207447)
31. Kosik K. S., Joachim C. L., Selkoe D. J., Microtubule-associated protein tau () is a major antigenic component of paired helical filaments in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1986 83 11 4044 4048 (Pubitemid 16062419)
32. Weingarten M. D., Lockwood A. H., Hwo S. Y., Kirschner M. W., A protein factor essential for microtubule assembly Proceedings of the National Academy of Sciences of the United States of America 1975 72 5 1858 1862
33. Seubert P., Mawal-Dewan M., Barbour R., Jakes R., Goedert M., Johnson G. V. W., Litersky J. M., Schenk D., Lieberburg I., Trojanowski J. Q., Lee V. M. Y., Detection of phosphorylated Ser in fetal tau, adult tau, and paired helical filament tau Journal of Biological Chemistry 1995 270 32 18917 18922
34. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshitake R., Takei Y., Noda T., Hirokawa N., Altered microtubule organization in small-calibre axons of mice lacking tau protein Nature 1994 369 6480 488 491 (Pubitemid 24210568)
35. Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q., Lee-V. M. Y., Abnormal tau phosphorylation at Ser 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding Neuron 1993 10 6 1089 1099 (Pubitemid 23194399)
36. Lee V. M. Y., Goedert M., Trojanowski J. Q., Neurodegenerative tauopathies Annual Review of Neuroscience 2001 24 1121 1159 (Pubitemid 32695256)
37. Sun W., Qureshi H. Y., Cafferty P. W., Sobue K., Agarwal-Mawal A., Neufield K. D., Paudel H. K., Glycogen synthase kinase-3 is complexed with tau protein in brain microtubules Journal of Biological Chemistry 2002 277 14 11933 11940 (Pubitemid 34952752)
38. Ferrer I., Barrachina M., Puig B., Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's diasese, Pick's disease, progressive supranuclear palsy and corticobasal degeneration Acta Neuropathologica 2002 104 6 583 591 (Pubitemid 36075423)
39. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C. A., Imahori K., Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 and cyclin-dependent kinase 5, a component of TPK II Acta Neuropathologica 1996 92 3 232 241 (Pubitemid 26278953)
40. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P., Anderton B. H., Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase Neuroscience Letters 1992 147 1 58 62
41. Mandelkow E. M., Drewes G., Biernat J., Gustke N., van Lint J., Vandenheede J. R., Mandelkow E., Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau FEBS Letters 1992 314 3 315 321 (Pubitemid 23005680)
42. Lovestone S., Reynolds C. H., Latimer D., Davis D. R., Anderton B. H., Gallo J. M., Hanger D., Mulot S., Marquardt B., Stabel S., Woodgett J. R., Miller C. C. J., Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells Current Biology 1994 4 12 1077 1086 (Pubitemid 124001594)
43. Moreno F. J., Medina M., Perez M., Montejo De Garcini E., Avila J., Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin) FEBS Letters 1995 372 1 65 68
44. Sperbera B. R., Leight S., Goedert M., Lee V. M., Glycogen synthase kinase-3 phosphorylates tau protein at multiple sites in intact cells Neuroscience Letters 1995 197 2 149 153
45. Li T., Paudel H. K., Glycogen synthase kinase 3 phosphorylates Alzheimer's disease-specific Ser 396 of microtubule-associated protein tau by a sequential mechanism Biochemistry 2006 45 10 3125 3133 (Pubitemid 43376331)
46. Brownlees J., Irving N. G., Brion J. P., Gibb B. J. M., Wagner U., Woodgett J., Miller C. C. J., Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3 transgenes NeuroReport 1997 8 15 3251 3255 (Pubitemid 27461376)
47. Lucas J. J., Hernndez F., Gmez-Ramos P., Morn M. A., Hen R., Avila J., Decreased nuclear -catenin, tau hyperphosphorylation and neurodegeneration in GSK-3 conditional transgenic mice The EMBO Journal 2001 20 1-2 27 39 (Pubitemid 32099099)
48. Engel T., Goi-Oliver P., Gomez-Ramos P., Morn M. A., Lucas J. J., Avila J., Hernndez F., Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3 β Neuroscience 2008 157 4 772 780
49. Spittaels K., van den Haute C., van Dorpe J., Geerts H., Mercken M., Bruynseels K., Lasrado R., Vandezande K., Laenen I., Boon T., van Lint J., Vandenheede J., Moechars D., Loos R., van Leuven F., Glycogen synthase kinase-3 phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice Journal of Biological Chemistry 2000 275 52 41340 41349 (Pubitemid 32054968)
50. Malm T. M., Iivonen H., Goldsteins G., Keksa-Goldsteine V., Ahtoniemi T., Kanninen K., Salminen A., Auriola S., van Groen T., Tanila H., Koistinaho J., Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting -amyloid burden Journal of Neuroscience 2007 27 14 3712 3721 (Pubitemid 46557689)
51. Shi H. R., Zhu L. Q., Wang S. H., Liu X. A., Tian Q., Zhang QI., Wang Q., Wang J. Z., 17 -estradiol attenuates glycogen synthase kinase-3 activation and tau hyperphosphorylation in Akt-independent manner Journal of Neural Transmission 2008 115 6 879 888
52. Zhang Z., Zhao R., Qi J., Wen S., Tang Y., Wang D., Inhibition of glycogen synthase kinase-3 by Angelica sinensis extract decreases -amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons Journal of Neuroscience Research 2011 89 3 437 447
53. Takahashi M., Yasutake K., Tomizawa K., Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3 -dependent phosphorylation of juvenile tau in cultured hippocampal neurons Journal of Neurochemistry 1999 73 5 2073 2083 (Pubitemid 29491822)
54. Leclerc S., Garnier M., Hoessel R., Marko D., Bibb J. A., Snyder G. L., Greengard P., Biernat J., Wu Y. Z., Mandelkow E. M., Eisenbrand G., Meijert L., Indirubins inhibit glycogen synthase kinase-3 and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? Journal of Biological Chemistry 2001 276 1 251 260 (Pubitemid 32050314)
55. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., Duff K., Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo Proceedings of the National Academy of Sciences of the United States of America 2005 102 19 6990 6995 (Pubitemid 40675429)
56. Kozikowski A. P., Gaisina I. N., Petukhov P. A., Sridhar J., King L. T., Blond S. Y., Duka T., Rusnak M., Sidhu A., Highly potent and specific GSK-3 inhibitors that block tau phosphorylation and decrease -synuclein protein expression in a cellular model of Parkinson's disease ChemMedChem 2006 1 2 256 266 (Pubitemid 43700306)
57. Greco S. J., Sarkar S., Casadesus G., Zhu X., Smith M. A., Ashford J. W., Johnston J. M., Tezapsidis N., Leptin inhibits glycogen synthase kinase-3 to prevent tau phosphorylation in neuronal cells Neuroscience Letters 2009 455 3 191 194
58. Crouch P. J., Lin W. H., Adlard P. A., Cortes M., Lal V., Filiz G., Perez K. A., Nurjono M., Caragounis A., Du T., Laughton K., Volitakis I., Bush A. I., Li Q. X., Masters C. L., Cappai R., Cherny R. A., Donnelly P. S., White A. R., Barnham K. J., Increasing Cu bioavailability inhibits A oligomers and tau phosphorylation Proceedings of the National Academy of Sciences of the United States of America 2009 106 2 381 386
59. Lovestone S., Hartley C. L., Pearce J., Anderton B. H., Phosphorylation of tau by glycogen synthase kinase-3 in intact mammalian cells: the effects on the organization and stability of microtubules Neuroscience 1996 73 4 1145 1157 (Pubitemid 26194338)
60. Sang H., Lu Z., Li Y., Ru B., Wang W., Chen J., Phosphorylation of tau by glycogen synthase kinase 3 in intact mammalian cells influences the stability of microtubules Neuroscience Letters 2001 312 3 141 144 (Pubitemid 32972143)
61. Utton M. A., Vandecandelaere A., Wagner U., Reynolds C. H., Gibb G. M., Miller C. G. J., Bayley P. M., Anderton B. H., Phosphorylation of tau by glycogen synthase kinase 3 affects the ability of tau to promote microtubule self-assembly Biochemical Journal 1997 323 3 741 747 (Pubitemid 27202345)
62. Cho J. H., Johnson G. V. W., Glycogen synthase kinase 3 phosphorylates tau at both primed and unprimed sites: differential impact on microtubule binding Journal of Biological Chemistry 2003 278 1 187 193 (Pubitemid 36043561)
63. Leroy K., Menu R., Conreur J. L., Dayanandan R., Lovestone S., Anderton B. H., Brion J. P., The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3 activity FEBS Letters 2000 465 1 34 38 (Pubitemid 30012111)
64. Tatebayashi Y., Haque N., Tung Y. C., Iqbal K., Grundke-Iqbal I., Role of tau phosphorylation by glycogen synthase kinase-3 in the regulation of organelle transport Journal of Cell Science 2004 117 9 1653 1663 (Pubitemid 38559298)
65. Cuchillo-Ibanez I., Seereeram A., Byers H. L., Leung K. Y., Ward M. A., Anderton B. H., Hanger D. P., Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin FASEB Journal 2008 22 9 3186 3195
66. Dill J., Wang H., Zhou F., Li S., Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS Journal of Neuroscience 2008 28 36 8914 8928
67. Shim S. B., Lim H. J., Chae K. R., Kim C. K., Hwang D. Y., Jee S. W., Lee S. H., Sin J. S., Leem Y. H., Lee S. H., Cho J. S., Lee H. H., Choi S. Y., Kim Y. K., Tau overexpression in transgenic mice induces glycogen synthase kinase 3 and -catenin phosphorylation Neuroscience 2007 146 2 730 740 (Pubitemid 46617052)
68. Cho J. H., Johnson G. V. W., Glycogen synthase kinase 3 induces caspase-cleaved tau aggregation in situ Journal of Biological Chemistry 2004 279 52 54716 54723 (Pubitemid 40053216)
69. Peng J. H., Zhang C. E., Wei W., Hong X. P., Pan XI. P., Wang J. Z., Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats Neuropharmacology 2007 52 7 1521 1527 (Pubitemid 46695738)
70. Chun W., Johnson G. V. W., Activation of glycogen synthase kinase 3 promotes the intermolecular association of tau: the use of fluorescence resonance energy transfer microscopy Journal of Biological Chemistry 2007 282 32 23410 23417 (Pubitemid 47311920)
71. Engel T., Lucas J. J., Gmez-Ramos P., Moran M. A., vila J., Hernndez F., Cooexpression of FTDP-17 tau and GSK-3 in transgenic mice induce tau polymerization and neurodegeneration Neurobiology of Aging 2006 27 9 1258 1268 (Pubitemid 44088576)
72. Engel T., Hernndez F., Avila J., Lucas J. J., Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3 Journal of Neuroscience 2006 26 19 5083 5090 (Pubitemid 44315289)
73. Prez M., Hernndez F., Lim F., Daz-Nido J., Avila J., Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model Journal of Alzheimer's Disease 2003 5 4 301 308 (Pubitemid 37411777)
74. Nakashima H., Ishihara T., Suguimoto P., Yokota O., Oshima E., Kugo A., Terada S., Hamamura T., Trojanowski J. Q., Lee V. M. Y., Kuroda S., Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies Acta Neuropathologica 2005 110 6 547 556 (Pubitemid 41763984)
75. Engel T., Goi-Oliver P., Lucas J. J., Avila J., Hernndez F., Chronic lithium administration to FTDP-17 tau and GSK-3 overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert Journal of Neurochemistry 2006 99 6 1445 1455 (Pubitemid 44924224)
76. Gmez de Barreda E., Prez M., Gmez Ramos P., de Cristobal J., Martn-Maestro P., Morn A., Dawson H. N., Vitek M. P., Lucas J. J., Hernndez F., Avila J., Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits Neurobiology of Disease 2010 37 3 622 629
77. Hernndez F., Prez M., Lucas J. J., Mata A. M., Bhat R., Avila J., Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35: implications for Alzheimer's disease Journal of Biological Chemistry 2004 279 5 3801 3806 (Pubitemid 38140625)
78. Martin L., Magnaudeix A., Esclaire F., Yardin C., Terro F., Inhibition of glycogen synthase kinase-3 downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A Brain Research 2009 1252 C 66 75
79. Rametti A., Esclaire F., Yardin C., Cogn N., Terro F., Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection Neuroscience Letters 2008 434 1 93 98
80. Gtz J., Chen F., van Dorpe J., Nitsch R. M., Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A 42 fibrils Science 2001 293 5534 1491 1495 (Pubitemid 32807681)
81. Melov S., Adlard P. A., Morten K., Johnson F., Golden T. R., Hinerfeld D., Schilling B., Mavros C., Masters C. L., Volitakis I., Li Q. X., Laughton K., Hubbard A., Cherny R. A., Gibson B., Bush A. I., Mitochondrial oxidative stress causes hyperphosphorylation of tau PLoS ONE 2007 2 6, article e536
82. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K., Tau protein kinase I is essential for amyloid -protein-induced neurotoxicity Proceedings of the National Academy of Sciences of the United States of America 1993 90 16 7789 7793 (Pubitemid 23250036)
83. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., Imahori K., Exposure of rat hippocampal neurons to amyloid peptide (2535) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 β Neuroscience Letters 1996 203 1 33 36
84. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., Sato K., Spherical aggregates of -amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3 Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6370 6375 (Pubitemid 36666588)
85. Ma Q.-L., Lim G. P., Harris-White M. E., Yang F., Ambegaokar S. S., Ubeda O. J., Glabe C. G., Teter B., Frautschy S. A., Cole G. M., Antibodies against -amyloid reduce A oligomers, glycogen synthase kinase-3 activation and phosphorylation in vivo and in vitro Journal of Neuroscience Research 2006 83 3 374 384 (Pubitemid 43184401)
86. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., Ishiguro K., Yamaguchi H., Activation of tau protein kinase I/glycogen synthase kinase-3 by amyloid peptide (2535) enhances phosphorylation of tau in hippocampal neurons Neuroscience Research 1998 31 4 317 323 (Pubitemid 28446014)
87. Aplin A. E., Jacobsen J. S., Anderton B. H., Gallo J. M., Effect of increased glycogen synthase kinase-3 activity upon the maturation of the amyloid precursor protein in transfected cells NeuroReport 1997 8 3 639 643 (Pubitemid 27128208)
88. Koh S. H., Noh M. Y., Kim S. H., Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3 Brain Research 2008 1188 1 254 262 (Pubitemid 350296066)
89. Terwel D., Muyllaert D., Dewachter I., Borghgraef P., Croes S., Devijver H., van Leuven F., Amyloid activates GSK-3 to aggravate neuronal tauopathy in bigenic mice American Journal of Pathology 2008 172 3 786 798 (Pubitemid 351354550)
90. Ghosal K., Vogt D. L., Liang M., Shen Y., Lamb B. T., Pimplikar S. W., Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain Proceedings of the National Academy of Sciences of the United States of America 2009 106 43 18367 18372
91. Amadoro G., Corsetti V., Ciotti M. T., Florenzano F., Capsoni S., Amato G., Calissano P., Endogenous A causes cell death via early tau hyperphosphorylation. Neurobiology of Aging. In press
92. Roberson E. D., Scearce-Levie K., Palop J. J., Yan F., Cheng I. H., Wu T., Gerstein H., Yu G. Q., Mucke L., Reducing endogenous tau ameliorates amyloid -induced deficits in an Alzheimer's disease mouse model Science 2007 316 5825 750 754 (Pubitemid 46717684)
93. Ittner L. M., Ke Y. D., Delerue F., Bi M., Gladbach A., van Eersel J., Wlfing H., Chieng B. C., Christie M. J., Napier I. A., Eckert A., Staufenbiel M., Hardeman E., Gtz J., Dendritic function of tau mediates amyloid- toxicity in alzheimer's disease mouse models Cell 2010 142 3 387 397
94. Aplin A. E., Gibb G. M., Jacobsen J. S., Gallo J. M., Anderton B. H., In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3 Journal of Neurochemistry 1996 67 2 699 707 (Pubitemid 26255667)
95. Terracciano C., Nogalska A., Engel W. K., Askanas V., In APP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of APP751 and GSK3 activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis Journal of Neurochemistry 2010 112 2 389 396
96. Kirschenbaum F., Hsu S. C., Cordell B., McCarthy J. V., Glycogen synthase kinase-3 regulates presenilin 1 C-terminal fragment levels Journal of Biological Chemistry 2001 276 33 30701 30707
97. Kirschenbaum F., Hsu S. C., Cordell B., McCarthy J. V., Substitution of a glycogen synthase kinase-3 phosphorylation site in presenilin 1 separates presenilin function from -catenin signaling Journal of Biological Chemistry 2001 276 10 7366 7375
98. Twomey C., McCarthy J. V., Presenilin-1 is an unprimed glycogen synthase kinase-3 substrate FEBS Letters 2006 580 17 4015 4020 (Pubitemid 44037562)
99. Phiel C. J., Wilson C. A., Lee V. M. Y., Klein P. S., GSK-3 regulates production of Alzheimer's disease amyloid- peptides Nature 2003 423 6938 435 439 (Pubitemid 36626994)
100. Ryder J., Su Y., Liu F., Li B., Zhou Y., Ni B., Divergent roles of GSK3 and CDK5 in APP processing Biochemical and Biophysical Research Communications 2003 312 4 922 929 (Pubitemid 37490904)
101. Rockenstein E., Torrance M., Adame A., Mante M., Bar-on P., Rose J. B., Crews L., Masliah E., Neuroprotective effects of regulators of the glycogen synthase kinase-3 signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation Journal of Neuroscience 2007 27 8 1981 1991
102. Seren L., Coma M., Rodrguez M., Snchez-Ferrer P., Snchez M. B., Gich I., Agull J. M., Prez M., Avila J., Guardia-Laguarta C., Clarimn J., Lle A., Gmez-Isla T., A novel GSK-3 inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo Neurobiology of Disease 2009 35 3 359 367
103. Decker H., Lo K. Y., Unger S. M., Ferreira S. T., Silverman M. A., Amyloid- peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3 in primary cultured hippocampal neurons Journal of Neuroscience 2010 30 27 9166 9171
104. Cookson M. R., The biochemistry of Parkinson's disease Annual Review of Biochemistry 2005 74 29 52 (Pubitemid 40995500)
105. Lei P., Ayton S., Finkelstein D. I., Adlard P. A., Masters C. L., Bush A. I., Tau protein: relevance to Parkinson's disease International Journal of Biochemistry and Cell Biology 2010 42 11 1775 1778
106. Simn-Snchez J., Schulte C., Bras J. M., Sharma M., Gibbs J. R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S. W., Hernandez D. G., Krger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M. A., Illig T., Gieger C., Houlden H., Steffens M., Okun M. S., Racette B. A., Cookson M. R., Foote K. D., Fernandez H. H., Traynor B. J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S. J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N. W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J. A., Singleton A. B., Gasser T., Genome-wide association study reveals genetic risk underlying Parkinson's disease Nature Genetics 2009 41 12 1308 1312
107. Edwards T. L., Scott W. K., Almonte C., Burt A., Powell E. H., Beecham G. W., Wang L., Zchner S., Konidari I., Wang G., Singer C., Nahab F., Scott B., Stajich J. M., Pericak-Vance M., Haines J., Vance J. M., Martin E. R., Genome-Wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for parkinson disease Annals of Human Genetics 2010 74 2 97 109
108. Nagao M., Hayashi H., Glycogen synthase kinase-3beta is associated with Parkinson's disease Neuroscience Letters 2009 449 2 103 107
109. Wills J., Jones J., Haggerty T., Duka V., Joyce J. N., Sidhu A., Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia Experimental Neurology 2010 225 1 210 218
110. Duka T., Duka V., Joyce J. N., Sidhu A., α-synuclein contributes to GSK-3 -catalyzed Tau phosphorylation in Parkinson's disease models FASEB Journal 2009 23 9 2820 2830
111. Armentero M. T., Sinforiani E., Ghezzi C., Bazzini E., Levandis G., Ambrosi G., Zangaglia R., Pacchetti C., Cereda C., Cova E., Basso E., Celi D., Martignoni E., Nappi G., Blandini F., Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease. Neurobiology of Aging. In press
112. Kwok J. B. J., Hallupp M., Loy C. T., Chan D. K. Y., Woo J., Mellick G. D., Buchanan D. D., Silburn P. A., Halliday G. M., Schofield P. R., GSK3B polymorphisms alter transcription and splicing in Parkinson's disease Annals of Neurology 2005 58 6 829 839 (Pubitemid 41746872)
113. Garca-Gorostiaga I., Snchez-Juan P., Mateo I., Rodrguez-Rodrguez E., Snchez-Quintana C., Del Olmo S. C., Vzquez-Higuera J. L., Berciano J., Combarros O., Infante J., Glycogen synthase kinase-3 and tau genes interact in Parkinson's and Alzheimer's diseases Annals of Neurology 2009 65 6 759 761
114. Khandelwal P. J., Dumanis S. B., Feng L. R., Maguire-Zeiss K., Rebeck G., Lashuel H. A., Moussa C. E., Parkinson-related parkin reduces -synuclein phosphorylation in a gene transfer model Molecular Neurodegeneration 2010 5 1 47
115. Wang W., Yang Y., Ying C., Li W., Ruan H., Zhu X., You Y., Han Y., Chen R., Wang Y., Li M., Inhibition of glycogen synthase kinase-3 protects dopaminergic neurons from MPTP toxicity Neuropharmacology 2007 52 8 1678 1684 (Pubitemid 46843143)
116. Phiel C. J., Klein P. S., Molecular targets of lithium action Annual Review of Pharmacology and Toxicology 2001 41 789 813 (Pubitemid 32385907)
117. Cade J. F., Lithium salts in the treatment of psychotic excitement The Medical Journal of Australia 1949 2 10 349 352
118. Fountoulakis K. N., Vieta E., Bouras C., Notaridis G., Giannakopoulos P., Kaprinis G., Akiskal H., A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? International Journal of Neuropsychopharmacology 2008 11 2 269 287 (Pubitemid 351231818)
119. O'Brien W. T., Harper A. D., Jov F., Woodgett J. R., Maretto S., Piccolo S., Klein P. S., Glycogen synthase kinase-3 haploinsufficiency mimics the behavioral and molecular effects of lithium Journal of Neuroscience 2004 24 30 6791 6798 (Pubitemid 38993901)
120. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J. A., Steckler T., Transgenic mice overexpressing glycogen synthase kinase 3 : a putative model of hyperactivity and mania Journal of Neuroscience 2006 26 35 9022 9029 (Pubitemid 44319393)
121. Klein P. S., Melton D. A., A molecular mechanism for the effect of lithium on development Proceedings of the National Academy of Sciences of the United States of America 1996 93 16 8455 8459 (Pubitemid 26269579)
122. Ryves W. J., Harwood A. J., Lithium inhibits glycogen synthase kinase-3 by competition for magnesium Biochemical and Biophysical Research Communications 2001 280 3 720 725 (Pubitemid 32924489)
123. Chalecka-Franaszek E., Chuang DE. M., Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons Proceedings of the National Academy of Sciences of the United States of America 1999 96 15 8745 8750 (Pubitemid 29354862)
124. De Sarno P., Li X., Jope R. S., Regulation of Akt and glycogen synthase kinase-3 phosphorylation by sodium valproate and lithium Neuropharmacology 2002 43 7 1158 1164 (Pubitemid 36009369)
125. Hedgepeth C. M., Conrad L. J., Zhang J., Huang H. C., Lee V. M. Y., Klein P. S., Activation of the Wnt signaling pathway: a molecular mechanism for lithium action Developmental Biology 1997 185 1 82 91 (Pubitemid 27244219)
126. Caccamo A., Oddo S., Tran L. X., LaFerla F. M., Lithium reduces tau phosphorylation but not A or working memory deficits in a transgenic model with both plaques and tangles American Journal of Pathology 2007 170 5 1669 1675 (Pubitemid 47339311)
127. Hong M., Chen D. C. R., Klein P. S., Lee V. M. Y., Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3 Journal of Biological Chemistry 1997 272 40 25326 25332 (Pubitemid 27415724)
128. Muoz-Montao J. R., Moreno F. J., Avila J., Daz-Nido J., Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons FEBS Letters 1997 411 2-3 183 188 (Pubitemid 27301451)
129. Lovestone S., Davis D. R., Webster M. T., Kaech S., Brion J. P., Matus A., Anderton B. H., Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations Biological Psychiatry 1999 45 8 995 1003 (Pubitemid 29219620)
130. Sun X., Sato S., Murayama O., Murayama M., Park J. M., Yamaguchi H., Takashima A., Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100 Neuroscience Letters 2002 321 1-2 61 64 (Pubitemid 34185499)
131. Su Y., Ryder J., Li B., Wu X., Fox N., Solenberg P., Brune K., Paul S., Zhou Y., Liu F., Ni B., Lithium, a common drug for bipolar disorder treatment, regulates amyloid- precursor protein processing Biochemistry 2004 43 22 6899 6908 (Pubitemid 38720508)
132. Feyt C., Kienlen-Campard P., Leroy K., N'Kuli F., Courtoy P. J., Brion J. P., Octave J. N., Lithium chloride increases the production of amyloid- peptide independently from its inhibition of glycogen synthase kinase 3 Journal of Biological Chemistry 2005 280 39 33220 33227 (Pubitemid 41397118)
133. Selenica M. L., Jensen H. S., Larsen A. K., Pedersen M. L., Helboe L., Leist M., Lotharius J., Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation British Journal of Pharmacology 2007 152 6 959 979 (Pubitemid 350100498)
134. Tsaltas E., Kontis D., Boulougouris V., Papakosta V. M., Giannou H., Poulopoulou C., Soldatos C., Enhancing effects of chronic lithium on memory in the rat Behavioural Brain Research 2007 177 1 51 60 (Pubitemid 46054196)
135. Tsaltas E., Kyriazi T., Poulopoulou C., Kontis D., Maillis A., Enhancing effects of lithium on memory are not by-products of learning or attentional deficits Behavioural Brain Research 2007 180 2 241 245 (Pubitemid 46719431)
136. Sofola O., Kerr F., Rogers I., Killick R., Augustin H., Gandy C., Allen M. J., Hardy J., Lovestone S., Partridge L., Inhibition of GSK-3 ameliorates A pathology in an adult-onset Drosophila model of Alzheimer's disease PLoS Genetics 2010 6 9
137. Toledo E. M., Inestrosa N. C., Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1E9 mouse model of Alzheimer's disease Molecular Psychiatry 2010 15 3 272 285
138. Fiorentini A., Rosi M. C., Grossi C., Luccarini I., Casamenti F., Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mice PLoS ONE 2010 5 12
139. Leroy K., Ando K., Hraud C., Yilmaz Z., Authelet M., Boeynaems J.-M., Bue L., De Decker R., Brion J.-P., Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology Journal of Alzheimer's Disease 2010 19 2 705 719
140. Havens W. W., Cole J., Successful treatment of dementia with lithium Journal of Clinical Psychopharmacology 1982 2 1 71 72 (Pubitemid 13245196)
141. Tsaltas E., Kontis D., Boulougouris V., Papadimitriou G. N., Lithium and cognitive enhancement: leave it or take it? Psychopharmacology 2009 202 1-3 457 476
142. Nunes P. V., Forlenza O. V., Gattaz W. F., Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder British Journal of Psychiatry 2007 190 359 360 (Pubitemid 46580688)
143. Terao T., Nakano H., Inoue Y., Okamoto T., Nakamura J., Iwata N., Lithium and dementia: a preliminary study Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006 30 6 1125 1128 (Pubitemid 43928235)
144. Kessing L. V., Forman J. L., Andersen P. K., Does lithium protect against dementia? Bipolar Disorders 2010 12 1 87 94
145. Macdonald A., Briggs K., Poppe M., Higgins A., Velayudhan L., Lovestone S., A feasibility and tolerability study of lithium in Alzheimer's disease International Journal of Geriatric Psychiatry 2008 23 7 704 711
146. Dunn N., Holmes C., Mullee M., Does lithium therapy protect against the onset of dementia? Alzheimer Disease and Associated Disorders 2005 19 1 20 22 (Pubitemid 40488659)
147. Hampel H., Ewers M., Brger K., Annas P., Mrtberg A., Bogstedt A., Frlich L., Schrder J., Schnknecht P., Riepe M. W., Kraft I., Gasser T., Leyhe T., Mller H. J., Kurz A., Basun H., Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study Journal of Clinical Psychiatry 2009 70 6 922 931
148. Leyhe T., Eschweiler G. W., Stransky E., Gasser T., Annas P., Basun H., Laske C., Increase of bdnf serum concentration in lithium treated patients with early Alzheimer's disease Journal of Alzheimer's Disease 2009 16 3 649 656
149. Youdim M. B. H., Arraf Z., Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax Neuropharmacology 2004 46 8 1130 1140 (Pubitemid 38529937)
150. Friedman E., Gershon S., Effect of lithium on brain dopamine Nature 1973 243 5409 520 521
151. Dziedzicka-Wasylewska M., Makowiak M., Fijat K., Wdzony K., Adaptive changes in the rat dopaminergic transmission following repeated lithium administration Journal of Neural Transmission 1996 103 7 765 776 (Pubitemid 26383655)
152. Yong Y., Ding H., Fan Z., Luo J., Ke Z.-J., Lithium fails to protect dopaminergic neurons in the 6-ohda model of parkinson's disease Neurochemical Research 2010 36 3 367 374
153. Feng H. L., Leng Y., Ma C. H., Zhang J., Ren M., Chuang D. M., Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model Neuroscience 2008 155 3 567 572
154. Fornai F., Longone P., Cafaro L., Kastsiuchenka O., Ferrucci M., Manca M. L., Lazzeri G., Spalloni A., Bellio N., Lenzi P., Modugno N., Siciliano G., Isidoro C., Murri L., Ruggieri S., Paparelli A., Lithium delays progression of amyotrophic lateral sclerosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 6 2052 2057 (Pubitemid 351439463)
155. Gill A., Kidd J., Vieira F., Thompson K., Perrin S., No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS PLoS ONE 2009 4 8
156. Aggarwal S. P., Zinman L., Simpson E., McKinley J., Jackson K. E., Pinto H., Kaufman P., Conwit R. A., Schoenfeld D., Shefner J., Cudkowicz M., Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial The Lancet Neurology 2010 9 5 481 488